How to Read Supplement Labels: Dose, Form, and Why More Is Not Always Better

Key Takeaways
- A clinically informed supplement dose is backed by research in people. It is matched to the ingredient’s form. And it is easy to take every day, for years.
- Bigger numbers on a label do not always mean bigger effects in the body. Most active ingredients hit an absorption ceiling long before the dose looks impressive. That is the megadose trap.
- The form an ingredient takes can matter as much as the milligrams. The form drives how much of it your body actually absorbs.
- Consistency is what adds up over time. A simpler routine is easier to keep through busy weeks and travel. So simplifying a supplement stack into one daily longevity stack is a smart move on its own.
- Learning how to read supplement labels is mostly about knowing what a good one shows. It gives exact amounts and names the form of each ingredient. It also gives a reason for the dose you can check against published research.
How to Read Supplement Labels: Why Skepticism Comes First
Skepticism comes first because the label is written by the company selling the product, and in the United States most of what it claims is not checked by anyone before the bottle reaches the shelf. That is why learning how to read supplement labels matters more here than in almost any other aisle.
Anyone who has spent a few years managing a healthy-aging routine already knows the supplement aisle is loud. Plenty of products. Plenty of claims. Plenty of numbers. More options rarely produce more clarity, and for most thoughtful buyers they produce the opposite: too many bottles, too many decisions, and a quiet uncertainty about what is actually worth taking.
Knowing how to read supplement labels narrows that down to three things: the exact amount of each active ingredient, the form that ingredient is in, and whether that amount lines up with what human research tested.
The uncertainty has real roots. In the United States, supplements fall under a 1994 law called DSHEA, the Dietary Supplement Health and Education Act. It works separately from the rules for prescription drugs. Under it, the Food and Drug Administration does not check most supplements for safety or effectiveness before they go on sale. Companies must keep their own products clean and labeled correctly, and the agency usually steps in only after a product is already on the shelf.
That puts the work of judging a product on the buyer. The law assumes the buyer is the filter. A supplement can say it supports normal body function, but it cannot legally claim to diagnose, treat, or prevent disease, and any such claim must carry the standard DSHEA disclaimer. The Federal Trade Commission also expects health claims to be truthful and backed by science. So when a label reads like a drug ad in disguise, a little skepticism is useful.
A clinically informed supplement dose is one answer to that uncertainty. It is also the idea behind ResilienZ Health. The company started from a simple frustration. In a national survey of American adults who take supplements, more than 70% were taking more than one product a day, and only 26.9% of those supplements were taken on a doctor’s recommendation. Most buyers are making that judgment alone, with the label as the only guide.
What Does a Clinically Informed Supplement Dose Actually Mean?
A clinically informed supplement dose is an amount of an active ingredient backed by published human research, matched to the ingredient form, and sensible inside a daily routine meant for long-term use. Enough to matter. In a form the body can use. Sized to take every day, for years.
The phrase deserves care, because it gets used loosely. “Clinically dosed” can mean the highest amount ever studied. It can mean a dose close to a published trial. Sometimes it means nothing more than a number on a label that name-drops a study somewhere.
A clinically informed supplement dose is the middle one, with two added rules. The form has to fit the dose’s purpose. And the dose has to be livable in a daily routine that includes other ingredients. A 1,000 mg curcumin dose from a trial is one kind of claim. The same amount in a poorly absorbed form, taken a few times and dropped within three weeks, is another.
The distinction that does most of the work is between “this ingredient has research behind it” and “this dose of this form has research behind it.” Most labels can claim the first. The second is the standard a thoughtful formula meets. It is also the core of evidence-based supplement dosing: match the amount to what the research tested, in a form the body can absorb.
That distinction matters. Most healthy-aging benefits come from cellular pathways supported regularly, in amounts the body can use, over years of steady intake. Short, intense interventions are a different kind of biology, with different expectations. The dose on a label is only the starting point for the judgment a buyer has to make.
Why More Is Not Always Better: The Science of Absorption Ceilings

The body does not absorb compounds in a straight, endless line. For many nutrients and phytochemicals (plant compounds with biological activity), there is a known ceiling. Past it, extra intake is cleared before the body can use it. That ceiling is the key to judging supplement megadosing claims, because it shows why a dose alone, without form and context, is an incomplete signal.
Vitamin C is the best-documented example. Pharmacokinetics is how the body absorbs, processes, and clears a compound, and plasma is the liquid part of blood where those levels are measured.
A depletion-repletion study in healthy volunteers mapped the whole curve. Plasma vitamin C climbs steeply between 30 and 100 mg a day, moves past the steep part of the curve at 200 mg a day, and reaches complete saturation at 1,000 mg a day; at single doses of 500 mg and higher, absorption falls off and the surplus is excreted. The authors concluded that daily doses above 400 mg have no evident value. This is the source of the “expensive urine” phrase often aimed at high-dose water-soluble supplements.
It is also why ResilienZ-12™ uses 90 mg of vitamin C rather than a gram-scale dose. That amount sits low on the curve, where absorption is still essentially complete, and it lands on top of whatever fruit and vegetables already supply rather than trying to replace them.
Plasma vitamin C saturates at 1,000 mg a day; the authors of the study concluded that daily doses above 400 mg have no evident value.
![]() |
The science: The body keeps blood levels of many water-soluble vitamins and antioxidants in check by limiting how much the gut absorbs. Past a certain dose, the gut takes in a smaller share and the kidneys clear the rest. The evidence: A depletion-repletion study in the Proceedings of the National Academy of Sciences fed seven volunteers seven daily doses of vitamin C, from 30 to 2,500 mg, and found that plasma concentrations followed a sigmoid curve, moving past the steep portion at 200 mg a day and reaching complete saturation at 1,000 mg a day (Levine et al., 1996). At single doses of 500 mg and higher, absorption fell off and the surplus was excreted. The authors concluded that daily doses above 400 mg have no evident value. What the studies used: The trial tested seven daily doses from 30 to 2,500 mg of vitamin C; ResilienZ-12™ provides 90 mg, low on the curve where absorption is still essentially complete. |
Fat-soluble compounds behave differently, and the difference matters. Vitamin E, lycopene, astaxanthin, and CoQ10 are not flushed out in urine as easily. At very high doses, they raise a different concern: slow buildup in tissue. So “expensive urine” fits water-soluble nutrients, while the high-dose worry for fat-soluble ones is gradual accumulation.
The same caution applies to high-dose antioxidants. A Cochrane review found that certain high-dose antioxidants, mainly beta-carotene, vitamin A, and vitamin E, were not linked to lower death rates, and in some groups were linked to higher risk. The finding is narrow. It points to dose discipline for these specific compounds, on biological grounds, rather than a verdict on antioxidants in general.
When Supplement Megadosing Hits a Metabolic Ceiling
The body’s absorption and processing systems are finite. Supplement megadosing does not reliably get more into the tissue. For water-soluble compounds, it mostly adds to the clearance workload without adding to what reaches the cells. For fat-soluble ones, the issue becomes buildup over time. Either way, a higher milligram count does not automatically mean a stronger effect.
So a considered daily dose makes more biological sense than chasing the largest number on a rival label. The right dose is chosen with the absorption ceiling and the ingredient’s form in mind. Supplement megadosing rests on a hunch that more is always better. Biology sets the ceilings that limit how much of any compound the body can actually use.
Four Supplement Formulation Traps Worth Naming
Plenty of supplements are well designed. Plenty are not. Four common formulation traps explain most of the gap between an impressive label and a useful product. A buyer who knows the signs can wave off most label theater in seconds, then focus on the products that earn a closer look. The four traps below show up across categories: multivitamins, longevity formulas, single-ingredient products, and combination stacks.
The Proprietary-Blend Trap
A label that lists “800 mg of Proprietary Healthy Aging Complex,” without naming the dose of each ingredient, hides the very thing a buyer needs. Proprietary blends are legal. But they look sophisticated while making real comparison hard. Without per-ingredient amounts, a buyer cannot tell whether the formula matches the human evidence, whether two products double up on the same ingredient, or whether the key actives are present at amounts that do anything. Naming each ingredient and dose is the essence of transparent supplement dosing.
A serious formula is readable. Each ingredient named. Each dose stated. The reader should be able to hold the label next to the published research and reach an independent answer. That is what transparent supplement dosing looks like in practice, and a formulator confident in the dose rationale usually has no reason to hide it.
The Pixie-Dust Trap
Pixie-dusting means adding a recognizable, well-studied ingredient at a dose far below what the studies that built its reputation used. A label might name sulforaphane, resveratrol, or curcumin in microgram amounts buried in a long list. The names are there for marketing, at doses well under what the research actually used.
The test that separates cosmetic from meaningful is simple: does the amount on the label match the dose range studied in human trials for that specific form? A listed ingredient name tells you what is in the bottle. A research-aligned dose tells you whether the formula was built around the evidence. Transparent supplement dosing makes that check possible; pixie-dusting counts on the buyer never running it.
The Megadose Trap
Bigger numbers can carry their own kind of dishonesty. With some ingredients the limit is a saturation ceiling, as with vitamin C. With others the compound barely crosses the gut wall to begin with. Curcumin is the second kind. Poor absorption, fast metabolism, and rapid systemic clearance are the three factors that keep curcumin levels low in plasma and tissue, and a larger capsule does nothing about any of them.
The size of that gap is easy to underestimate. The review behind those three factors describes an open-label pilot in which 12 g of a standardized curcumin preparation taken with piperine left no trace of curcumin detectable in the blood of ten volunteers at any time point. Twelve grams, and nothing measurable in circulation. Supplement megadosing built on ingredients that behave this way sits closer to label theater than to biology.
![]() |
The science: Very little curcumin crosses the gut wall in the first place, and what does cross is broken down and cleared quickly. Both limits sit upstream of the dose, so raising the milligrams does not raise what reaches the cells. The evidence: A 2021 review on improving curcumin bioavailability in Pharmaceutics names poor absorption, fast metabolism, and rapid systemic clearance as the main reasons plasma and tissue levels stay low (Tabanelli, Brogi, & Calderone, 2021). The review also covers the delivery methods, phospholipid carriers among them, that address absorption directly rather than trying to overwhelm it. What the studies used: This anchor rests on a review of pharmacokinetic work rather than a single trial. It carries no single dose to set beside the 500 mg of Meriva® Curcumin Phytosome® in ResilienZ-12™. |
The Complexity Trap
A supplement can look impressive on paper and still fail in real life if the routine is too complicated to keep up. Healthy aging is built on consistency over years. It means showing up imperfectly but regularly, through busy weeks, work trips, a cold, or a parent in the hospital.
A 12-bottle morning ritual is fragile by design. The routines that survive the messy days are the ones that build up in the body over time. For most long-term health habits, sticking with it is the limiting factor, and a complicated routine is harder to keep. Simplifying a supplement stack, meaning fewer products while keeping good coverage across complementary pathways, is itself a health strategy. A research-aligned dose you never take is no dose at all.
How Bioavailable Supplement Forms Change the Math

For some ingredients, the dose on a label is only half the story. The form matters as much as the milligrams. Bioavailable supplement forms are part of what separates a clinically informed supplement dose from a label-impressive one, because the form decides how much of the listed amount actually reaches the blood and the cells. Four ingredients show how bioavailable supplement forms change the math.
Curcumin: A Form Problem Before a Dose Problem
Curcumin, the active compound in turmeric, is studied often in inflammation and cellular-defense research. It also has a well-known absorption problem. The molecule is fat-soluble, but the gut is a water-based environment, so standard curcumin extract is poorly absorbed, broken down fast, and cleared before it reaches useful levels in the blood. So swallowing a big dose of standard curcumin can still leave very little in circulation long enough to act.
Phytosome® delivery, used in Meriva® Curcumin Phytosome® from Indena®, wraps curcumin in a phospholipid matrix, a fat-based carrier shell that the gut lining accepts more readily than free curcumin. In a randomized crossover study, blood curcuminoid levels ran about 29 times higher after the phospholipid form than after the same dose of plain curcuminoids.
A higher dose of a poorly absorbed form can still deliver less to the blood than a moderate dose of a well-absorbed one. It is another illustration of why more is not always better in supplements. That phospholipid form, Meriva® Curcumin Phytosome®, is the curcumin source in ResilienZ-12™, dosed at 500 mg a day.
![]() |
The science: Curcumin does not dissolve in water, so the body absorbs little of it in plain form. A phospholipid carrier (a fat-based shell) repackages the curcumin so the gut wall treats it like a fat, which lets more of it cross into the blood. The evidence: In a randomized crossover study in the Journal of Natural Products, funded by Indena®, the ingredient maker, a lecithin-based curcumin reached roughly 29 times the total blood curcuminoid level of a standard curcuminoid mix at the same dose (Cuomo et al., 2011). The study also reports that even with far better absorption, plasma concentrations stayed below those needed to block most of curcumin’s anti-inflammatory targets directly. The practical takeaway is a real gain in bioavailability, at levels that still sit inside the supplement range. What the studies used: The published abstract states only that “clinically validated dosages were used.” It never names the milligram amount. So the trial dose cannot be set beside the 500 mg of Meriva® Curcumin Phytosome® in ResilienZ-12™ with any precision. |
Sulforaphane: A Conversion Problem That Requires Enzyme Activation
Sulforaphane is the cellular-defense compound behind much of broccoli’s reputation, especially broccoli sprouts, which are unusually rich in glucoraphanin. Sulforaphane forms from glucoraphanin, its plant-based precursor, with the help of an enzyme called myrosinase. Cooking destroys myrosinase. And the myrosinase made by gut bacteria varies a lot from person to person.
The takeaway for supplements is direct. A high dose of glucoraphanin, printed proudly on a label, may produce very little sulforaphane in a given person. Conversion of glucoraphanin to sulforaphane ranges from 1 to 40% across people, with a mean near 10%, and the spread is driven mainly by differences in each person’s gut bacteria. Preformed sulforaphane behaves nothing like that: 70 to 90% of the dose has turned up in the urine of every subject studied. A fortyfold spread between two people swallowing the same capsule is the argument for building the enzyme in.
Building active myrosinase into the ingredient itself, as in Activated BroccoRaphanin Plus® from CS Health, supports steadier sulforaphane production regardless of a person’s gut bacteria. The study behind those conversion figures also found that shielding the enzyme from stomach acid with an enteric coating raised conversion further, so surviving the stomach matters as much as being in the capsule. As with curcumin, the highest-impact choice lives in the form. That is the form decision built into ResilienZ-12™: an enzyme-paired sulforaphane source that does not leave the outcome to an individual’s gut bacteria.
CoQ10: A Dose Range With a Form Wrinkle
CoQ10 supports energy production in the mitochondria, the cell’s power plants, working within the electron transport chain, the sequence of steps that turns food and oxygen into cell energy. It also acts as a direct antioxidant in cell membranes. The body’s own CoQ10 drops with age, one reason it shows up so often in longevity formulas. A daily dose of 200 mg sits within the range studied in adults for heart and mitochondrial support.
Form matters here too, though the evidence is messier than the marketing. Head-to-head trials of ubiquinol and ubiquinone disagree with each other.
In 12 healthy volunteers given both forms at 200 mg a day in an identical soft-gel base, plasma CoQ10 rose further on ubiquinol, from 0.9 to 4.3 µg/mL against 0.9 to 2.5 µg/mL on ubiquinone. In 10 older men at the same dose, ubiquinol raised plasma CoQ10 to about 1.5 times each man’s own baseline while ubiquinone’s rise did not reach significance, though six of the 10 responded better to ubiquinol and two responded better to ubiquinone. In 21 adults aged 65 to 74, the gap between the two capsule forms did not reach significance at a 100 mg equivalent dose. What holds across the set is that the carrier lipids and the degree of solubilization move absorption more than the redox form does.
ResilienZ-12™ uses ubiquinone, the form carried by most of the long-term clinical research. The body converts it to the active form as needed, and its stability and track record suit a daily formula meant for steady use.
EGCG: A Polyphenol Without the Caffeine
EGCG (epigallocatechin gallate) is the main catechin in green tea. Catechins are plant antioxidants, and reviews of green tea polyphenols link them to antioxidant defense and heart-and-metabolic health markers. At 120 mg a day, it sits in the range commonly studied in adults. The decaffeinated form is a deliberate choice. It delivers the polyphenols without the caffeine, which suits anyone sensitive to stimulants and shows that the cellular support in a well-designed longevity formula is not stimulant-driven.
How to Read Supplement Labels: Six Questions for Any Supplement Facts Panel
Learning how to read supplement labels comes down to six questions you can ask of any panel. The signs that separate evidence-based supplement dosing from label theater are right there on the label, once you know what to look for. The six questions turn the idea of transparent supplement dosing into a checklist you can run on the shelf. Anyone who knows how to read a supplement label can work through all six in about a minute.
| Question | What to Look For | Why It Matters |
|---|---|---|
| Can the exact dose be read on the label? | Per-ingredient amounts in milligrams. | Without per-ingredient doses, comparison to research is impossible. |
| Is the ingredient form specified? | “Meriva® Curcumin Phytosome®,” not “curcumin”; “Activated BroccoRaphanin Plus® with myrosinase,” not “broccoli powder.” | Form often determines whether the listed dose actually reaches cells. |
| Is the amount in line with human evidence? | A dose comparable to, or transparently scaled from, trials in published research. | A clinically informed supplement dose makes sense in published context, not in marketing copy. |
| Is the routine realistic for daily use? | One to four capsules a day, taken with food, that survive a busy week. | Consistency outranks intensity for healthy aging. |
| Does the brand explain why the dose was chosen? | Plain-language rationale tied to the form and the evidence. | Clear reasoning is a trust signal that “clinically dosed” alone is not. |
| Are there independent quality controls? | cGMP (current good manufacturing practices) manufacturing, third-party identity and potency testing. | Identity, purity, and potency claims that are externally verified. |
A formula that passes all six is doing the work that “clinically dosed” is supposed to imply. A formula that passes one or two is using the language of seriousness without the substance. The quick reference below boils the same logic down to the signals a label sends at a glance. A clinically informed supplement dose is what passes that test.
| What a Thoughtful Label Shows | What to Be Cautious About |
|---|---|
| Exact amounts for each active ingredient | A “proprietary blend” with only a combined weight |
| Ingredient form specified where it matters (phytosomal, myrosinase-activated, ubiquinone) | Only the raw compound listed, with no form information |
| Claims that stay within structure/function language (what an ingredient supports, not what it treats) | Claims that read like disease treatment or diagnosis |
| Manufacturing standards noted (cGMP-certified, FDA-inspected facility) | No mention of manufacturing standards or testing |
| Third-party testing for identity, potency, and purity | No quality verification referenced |
| Clear daily directions that reflect realistic use | Complex, multi-step dosing instructions |
The supplements worth taking are the ones whose dose, form, and rationale survive a careful read of the label.
Why a Clinically Informed Supplement Dose Matters for Healthy Aging

The dose matters here because the benefit is cumulative: it comes from years of steady intake at amounts the body can absorb, which makes both the size of the dose and the livability of the routine part of the same question. Healthy-aging research has moved in a useful direction over the past decade. A 2024 review of biomarkers of aging catalogues the molecular, cellular, and physiological changes that track with age, alongside the techniques now available for measuring them. Aging is becoming a set of processes with numbers attached, rather than a single slope.
The lesson for a daily longevity stack is plain. Long-term cellular support comes from several complementary inputs, taken consistently, in bioavailable supplement forms the body can use, at amounts that match the evidence. A single ingredient at a heroic dose rarely sustains that work. This is where evidence-based supplement dosing earns its keep over the long run: amounts the research supports, in forms the body can use, taken daily.
Mitochondrial support shows how compounds can work together rather than alone. A review on CoQ10 and resveratrol describes how the two play different parts in the same problem: CoQ10 works directly inside the electron transport chain, while resveratrol acts upstream through sirtuin signaling, a cellular repair and stress-response pathway. The doses involved are modest. The same review cites the European Food Safety Authority’s position that resveratrol is safe as a food supplement at 150 mg a day, well inside what a single daily routine can carry.
That is the standard ResilienZ-12™ was built to. It brings together twelve complementary ingredients at clinically credible doses, including the CoQ10 and trans-resveratrol pairing above, in three vegan capsules, to support healthy aging as a daily longevity stack rather than a cabinet of bottles. The formula puts those principles into one disciplined routine, which is what a daily longevity stack can look like when dose, form, and routine are designed together.
Studies cited above describe individual ingredients, dietary patterns, and biological mechanisms, not the ResilienZ-12™ formula itself. Ingredient and dose selection in ResilienZ-12™ is informed by this research, not equivalent to it.
Frequently Asked Questions
What Does a Clinically Informed Supplement Dose Actually Mean?
A clinically informed supplement dose is an amount of an active ingredient backed by published human research, matched to the ingredient’s form, and small enough to take every day for years. It points to a dose that makes biological sense in context: meaningful in light of trials, and in a form the body can absorb.
Why Is More Not Always Better When It Comes to Supplements?
For many water-soluble vitamins and phytochemicals, the body’s absorption has a known ceiling. Past it, extra intake is cleared before reaching tissue, so more adds no benefit once absorption is full. For fat-soluble compounds at very high doses, buildup in tissue becomes a separate concern. Evidence-based supplement dosing weighs both, rather than defaulting to the biggest number.
Is the Megadose Trap Ever Worth It?
The megadose trap is rarely the best use of money for everyday healthy-aging support. Many active ingredients either saturate the body’s absorption or barely cross the gut wall to begin with, so extra milligrams are cleared instead of reaching the cells. A clinically informed supplement dose, paired with a routine you can keep, sits inside that absorption window. That is why supplement megadosing rarely earns its place.
Why Are Bioavailable Supplement Forms Important?
Bioavailable supplement forms decide how much of the listed dose actually reaches the blood and the cells. Curcumin in a phospholipid carrier crosses the gut wall far better than plain curcumin. A glucoraphanin source paired with active myrosinase makes far more sulforaphane than a precursor without the enzyme. The form is part of the dose, which is why bioavailable supplement forms matter.
How Do You Read Supplement Labels for Dose and Form?
You read supplement labels by checking three things: that each active ingredient is named, that its form is stated, and that its dose is given in milligrams rather than buried in a proprietary blend. That is enough to set the label beside the published human research and see whether the amounts are meaningful.
How Does Simplifying a Supplement Stack Help With Consistency?
Simplifying a supplement stack into one daily longevity stack means making one choice each morning instead of eight. Healthy aging is built on years of steady, imperfect follow-through. A single, well-designed routine has a better chance of getting done through the busy weeks when complex routines fall apart.
FDA Disclaimer
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
This article draws on 16 peer-reviewed sources, all linked in the references below.
References
Anand, P., Kunnumakkara, A. B., Newman, R. A., & Aggarwal, B. B. (2007). Bioavailability of curcumin: Problems and promises. Molecular Pharmaceutics, 4(6), 807–818.
Bjelakovic, G., Nikolova, D., Gluud, L. L., Simonetti, R. G., & Gluud, C. (2012). Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases. Cochrane Database of Systematic Reviews, (3), CD007176.
Chacko, S. M., Thambi, P. T., Kuttan, R., & Nishigaki, I. (2010). Beneficial effects of green tea: A literature review. Chinese Medicine, 5, 13.
Cuomo, J., Appendino, G., Dern, A. S., Schneider, E., McKinnon, T. P., Brown, M. J., Togni, S., & Dixon, B. M. (2011). Comparative absorption of a standardized curcuminoid mixture and its lecithin formulation. Journal of Natural Products, 74(4), 664–669.
Dulbecco, P., & Savarino, V. (2013). Therapeutic potential of curcumin in digestive diseases. World Journal of Gastroenterology, 19(48), 9256–9270.
Fahey, J. W., Wade, K. L., Stephenson, K. K., Panjwani, A. A., Liu, H., Cornblatt, G., Cornblatt, B. S., Ownby, S. L., Fuchs, E., Holtzclaw, W. D., & Cheskin, L. J. (2019). Bioavailability of sulforaphane following ingestion of glucoraphanin-rich broccoli sprout and seed extracts with active myrosinase: A pilot study of the effects of proton pump inhibitor administration. Nutrients, 11(7), 1489.
Fahey, J. W., Zhang, Y., & Talalay, P. (1997). Broccoli sprouts: An exceptionally rich source of inducers of enzymes that protect against chemical carcinogens. Proceedings of the National Academy of Sciences, 94(19), 10367–10372.
Gherardi, G., Corbioli, G., Ruzza, F., & Rizzuto, R. (2022). CoQ10 and resveratrol effects to ameliorate aged-related mitochondrial dysfunctions. Nutrients, 14(20), 4326.
Langsjoen, P. H., & Langsjoen, A. M. (2014). Comparison study of plasma coenzyme Q10 levels in healthy subjects supplemented with ubiquinol versus ubiquinone. Clinical Pharmacology in Drug Development, 3(1), 13–17.
Levine, M., Conry-Cantilena, C., Wang, Y., Welch, R. W., Washko, P. W., Dhariwal, K. R., Park, J. B., Lazarev, A., Graumlich, J. F., King, J., & Cantilena, L. R. (1996). Vitamin C pharmacokinetics in healthy volunteers: Evidence for a Recommended Dietary Allowance. Proceedings of the National Academy of Sciences, 93(8), 3704–3709.
Liu, L., Tao, H., Xu, J., Liu, L., & Nahata, M. C. (2024). Quantity, duration, adherence, and reasons for dietary supplement use among adults: Results from NHANES 2011–2018. Nutrients, 16(12), 1830.
López-Lluch, G., Del Pozo-Cruz, J., Sánchez-Cuesta, A., Cortés-Rodríguez, A. B., & Navas, P. (2019). Bioavailability of coenzyme Q10 supplements depends on carrier lipids and solubilization. Nutrition, 57, 133–140.
Pravst, I., Rodríguez Aguilera, J. C., Cortes Rodriguez, A. B., Jazbar, J., Locatelli, I., Hristov, H., & Žmitek, K. (2020). Comparative bioavailability of different coenzyme Q10 formulations in healthy elderly individuals. Nutrients, 12(3), 784.
Tabanelli, R., Brogi, S., & Calderone, V. (2021). Improving curcumin bioavailability: Current strategies and future perspectives. Pharmaceutics, 13(10), 1715.
Tao, X., Zhu, Z., Wang, L., Li, C., Sun, L., Wang, W., & Gong, W. (2024). Biomarkers of aging and relevant evaluation techniques: A comprehensive review. Aging and Disease, 15(3), 977–1005.
U.S. Food and Drug Administration. (n.d.). Dietary supplements. U.S. Food and Drug Administration.
Zhang, Y., Liu, J., Chen, X. Q., & Oliver Chen, C.-Y. (2018). Ubiquinol is superior to ubiquinone to enhance coenzyme Q10 status in older men. Food & Function, 9(11), 5653–5659.
About the author: Seanna Marceaux, MS RDN, is ResilienZ Health’s Chief Science Officer and the dietitian who vetted the ResilienZ-12™ formulation. A Texas-licensed registered dietitian nutritionist with nearly 20 years in public health and aging, she holds a master’s degree in Human Nutrition from Texas State University, where she teaches graduate nutrition courses, and she has published peer-reviewed research on nutrition and aging.
More about Seanna’s background, research, and role at ResilienZ Health



